Eligibility criteria
Condition
Alzheimer's Disease
Sex
Females and Males
Age
55-85 years
Inclusion criteria
Show details
- Mild to moderate Alzheimer's disease (MMSE 14-26)
- Good general health (such controlled conditions as Type 2 diabetes and hypertension
allowed)
Exclusion criteria
Show details
- Use of acetylcholinesterase inhibitors (donepezil, rivastigmine, or galantamine) or
memantine within 12 weeks of the start of the study
- Significant cardiovascular disease in the past 6 months
- Illness other than Alzheimer's disease that could contribute to cognitive impairment
- History of stroke or seizure disorder